FBODaily.com | FedBizOpps: MOD | B | In Vitro and Non-Clinical Evaluation of Locally-Acting Topical Dermal and Ophthalmic Formulation Properties

FBO DAILY - FEDBIZOPPS ISSUE OF MAY 12, 2019 FBO #6379
MODIFICATION

B -- In Vitro and Non-Clinical Evaluation of Locally-Acting Topical Dermal and Ophthalmic Formulation Properties

Notice Date: 5/10/2019
Notice Type: Modification
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: 4041 Powder Mill Road Beltsville MD 20705
ZIP Code: 20705
Solicitation Number: 19-223-SOL-00023
Response Due: 5/16/2019
Archive Date: 5/17/2019
Point of Contact: Richard Robinson, Lead Contract Specialist, Phone 3017966508
E-Mail Address: richard.robinson@fda.hhs.gov
Small Business Set-Aside: Total Small Business
Description: Amendment 2 : The purpose of this amendment is to provide the FDA responses to questions submitted after the solicitation question period closed. While the solicitation question period had closed, the FDA thought it would be prudent to provide this clarifying information for potential offerors. See attached for amendment details. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (10-MAY-2019); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
Web Link: Link To Document
(https://www.fbo.gov/spg/HHS/FDA/DCASC/19-223-SOL-00023/listing.html)
Place of Performance: Address: At Awardee Site; Country: US
Record: SN05308272-F 20190512/190510230036 (fbodaily.com)
Source: FedBizOpps Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's FBO Daily Index Page |